Welcome to TalkDiabetes.net, a home for all of your diabetes resources and information to help you in gaining better control of the condition.

We have a very friendly forum which you can discuss anything you like in and know you will receive quick replies.

All of the content within the website is very useful but please do take note that you should always talk with your health care professional, this site will not replace your health care team but it will give you a little advice from people with experience.

Please do enjoy your visit and feel free to contact us with feedback and suggestions.

Take care!

Interview: Type 1 Diabetes Cure Trial from David Edelman on Vimeo.

If you or a loved one has type 1 diabetes, this interview with Dr. Denise Faustman is a must-watch. Dr. Faustman's lab was the first in the world to cure naturally diabetic mice. A clinical trial is underway to test this cure in human beings.

BACKGROUND
In 2003, after over a decade of work, Dr. Faustman became the first person to cure diabetes in naturally diabetic mice. This was not a treatment, like injecting islet cells or transplanting a pancreas. Dr. Faustman's mice had a genetic disorder that caused them to develop diabetes naturally. Once her mice reached old age (about a year in mice time), she treated them with a two-drug combination to kill the defective t-cells that were destroying their insulin producing function. The stunning result: the mice regrew their beta cells and began naturally producing insulin again! This experiment has been repeated and verified independently by a half dozen labs since.

In the past, there have been many false alarms on the "mouse cure" front. Treatments have been sold as cures or a reported cure was unable to be repeated. This is the real deal. The mice had diabetes into their old age, and this treatment cured them. Other labs have verified the results.

Dr. Faustman is now in the middle of a stage 1 clinical trial to test this technique in humans. Using special blood-testing equipment that's taken years and millions of dollars to develop, her team is measuring whether the BCG vaccine is able to measurably reduce the number of defective t-cells.